BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18203033)

  • 1. Newborn screening.
    Wilcken B; Wiley V
    Pathology; 2008 Feb; 40(2):104-15. PubMed ID: 18203033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for inborn errors of metabolism: a systematic review.
    Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
    Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
    Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
    Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tandem mass spectrometry as screening for inborn errors of metabolism].
    Campos H D
    Rev Med Chil; 2011 Oct; 139(10):1356-64. PubMed ID: 22286738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].
    Simonsen H
    Ugeskr Laeger; 2002 Nov; 164(48):5607-12. PubMed ID: 12523003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded newborn screening in Greece: 30 months of experience.
    Loukas YL; Soumelas GS; Dotsikas Y; Georgiou V; Molou E; Thodi G; Boutsini M; Biti S; Papadopoulos K
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S341-8. PubMed ID: 20721692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.
    Pandor A; Eastham J; Beverley C; Chilcott J; Paisley S
    Health Technol Assess; 2004 Mar; 8(12):iii, 1-121. PubMed ID: 14982654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.
    Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF
    Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening.
    Sahai I; Marsden D
    Crit Rev Clin Lab Sci; 2009; 46(2):55-82. PubMed ID: 19255915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening: an overview.
    Carreiro-Lewandowski E
    Clin Lab Sci; 2002; 15(4):229-38. PubMed ID: 12776783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating newborn screening programmes based on dried blood spots: future challenges.
    Dezateux C
    Br Med Bull; 1998; 54(4):877-90. PubMed ID: 10367420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for disease in the newborn: the evidence base for blood-spot screening.
    Wilcken B
    Pathology; 2012 Feb; 44(2):73-9. PubMed ID: 22198252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Advances for Newborn Screening of Inborn Errors of Metabolism by Capillary Electrophoresis-Mass Spectrometry (CE-MS).
    Shanmuganathan M; Britz-McKibbin P
    Methods Mol Biol; 2019; 1972():139-163. PubMed ID: 30847789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and therapeutic monitoring of inborn errors of metabolism in 100,077 newborns from Jining city in China.
    Yang CJ; Wei N; Li M; Xie K; Li JQ; Huang CG; Xiao YS; Liu WH; Chen XG
    BMC Pediatr; 2018 Mar; 18(1):110. PubMed ID: 29534692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding newborn screening: process, policy, and priorities.
    Moyer VA; Calonge N; Teutsch SM; Botkin JR;
    Hastings Cent Rep; 2008; 38(3):32-9. PubMed ID: 18581935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening newborns for inborn errors of metabolism by tandem mass spectrometry.
    Wilcken B; Wiley V; Hammond J; Carpenter K
    N Engl J Med; 2003 Jun; 348(23):2304-12. PubMed ID: 12788994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
    Zytkovicz TH; Fitzgerald EF; Marsden D; Larson CA; Shih VE; Johnson DM; Strauss AW; Comeau AM; Eaton RB; Grady GF
    Clin Chem; 2001 Nov; 47(11):1945-55. PubMed ID: 11673361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.